Visual Outcomes in Patients Contralaterally Implanted With PanOptix Pro and Clareon Vivity Compared to Bilateral Implantation of PanOptix Pro

NAEnrolling by invitationINTERVENTIONAL
Enrollment

346

Participants

Timeline

Start Date

August 5, 2025

Primary Completion Date

August 1, 2026

Study Completion Date

December 1, 2026

Conditions
CataractMultifocal Intraocular Lens
Interventions
DEVICE

Clareon PanOptix Pro and Clareon Vivity Intraocular Lens

Bilateral cataract surgery with contralateral implantation: Alcon Clareon PanOptix Pro (or PanOptix Pro Toric) intraocular lens in one eye and Alcon Clareon Vivity (or Vivity Toric) intraocular lens i

DEVICE

Clareon PanOptix Pro Intraocular Lenses

Bilateral cataract surgery with implantation of Alcon Clareon PanOptix Pro (or PanOptix Pro Toric) intraocular lenses in both eyes. All surgeries target emmetropia with residual astigmatism ≤0.50 diopters using toric IOLs or arcuate incisions as needed.

Trial Locations (5)

19004

Main Line Surgery Center, Bala-Cynwyd

19462

Shafer Vision Institute, Plymouth Meeting

21286

VIP Eye Care, Baltimore

56308

Vance Thompson Vision, Alexandria

59718

Vance Thompson Vision, Bozeman

All Listed Sponsors
lead

Brian Shafer

OTHER